Suppr超能文献

[稳定期慢性阻塞性肺疾病患者的药物治疗——重点关注吸入药物]

[Pharmacologic therapy for patients with stable chronic obstructive pulmonary disease--emphasis on inhaled agents].

作者信息

Nishimura K, Ikeda A, Koyama H, Tsukino M, Hajiro T, Izumi T

机构信息

Department of Pulmonary Medicine and Environmental Respiratory Disease, Kyoto University.

出版信息

Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Dec;34 Suppl:75-8.

PMID:9216189
Abstract

One dose of an anticholinergic agents has about the same bronchodilatory effect as one of a beta 2-agonist. Anticholinergic agents may be used first in patients with stable chronic obstructive pulmonary disease, because of the possible adverse effects of beta 2-agonists. One puff of a metered-dose inhaler will not cause a maximal bronchodilatory effect. Both anticholinergic and beta-adrenergic drugs cause dose-dependent bronchodilation when given as aerosols from metered-dose inhalers, and a combination of the two can provide better results. If the response to a single agent is unsatisfactory, use of higher doses is advised and the use of a combination of anticholinergic agents and beta-agonists is recommended. With regard to inhaled corticosteroids, a high dose of inhaled beclomethasone dipropionate (1,500 micrograms per day) can be a effective as oral corticosteroids. Step-by-step pharmacologic therapy with the drugs mentioned above should be used in outpatient management of patients with chronic obstructive pulmonary disease.

摘要

一剂抗胆碱能药物的支气管舒张作用与一剂β2激动剂大致相同。由于β2激动剂可能存在不良反应,在稳定期慢性阻塞性肺疾病患者中可优先使用抗胆碱能药物。定量气雾剂吸入一剂不会产生最大支气管舒张效果。抗胆碱能药物和β肾上腺素能药物通过定量气雾剂给药时均会产生剂量依赖性支气管舒张作用,两者联合使用效果更佳。如果对单一药物的反应不令人满意,建议使用更高剂量,并推荐联合使用抗胆碱能药物和β激动剂。关于吸入性糖皮质激素,高剂量吸入丙酸倍氯米松(每日1500微克)与口服糖皮质激素效果相当。在慢性阻塞性肺疾病患者的门诊管理中,应采用上述药物逐步进行药物治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验